2024 Archive Power Points

Speaker Presentations

Monday, July 8th

Biologics Summit Part II: Morning Session- 8:00 AM - 12:00 PM

• Breakthroughs in Drug Delivery and Medical Devices- Nigel Langley, Ph.D
• High-Volume Subcutaneous Injection Devices: Pushing the Injection Volume Boundaries- David Kang

Workshop: Recent Advances in the Use of Phospholipid Excipients- 8:00 AM - 12:00 PM

• Recent Advances in the Use of Phospholipid Excipients- Simon Drescher
• Radiocontrolled Drug Delivery with High-Z Element-Functionalized Liposomes- Mans Broekgaarden
• Phospholipids in Parenteral Depot Formulations: Recent Advances, Current Challenges and Future Opportunities- Dr. Paolo Luciani

• Advancing the Treatment of Infectious Diseases - the Key Role of Liposomes as Delivery Systems- M. Manuela Gaspar

• Introduction on the Use and Properties of Phospholipid Excipients- Dr. Peter Van Hoogevest

Workshop: Oral Drug Delivery From Today to Tomorrow: Latest Innovations and Best Practices: Part I -  9:00 AM - 12:00 PM

• Double Action of HPMCAS as a Binder and Precipitation Inhibitor in ASD tablets Prepared by Hot Melt Extrusion- Anisul Quadir Ph.D, MBA, R.Ph

Workshop: The Application of AI to Drug Delivery and Controlled Release

Workshop: Debunking the Myths of Subcutaneous Drug Delivery-1:00 PM - 5:00 PM

• Myth 1: Subcutaneous Delivery is Painful and Limited to Small Volumes- Sylvain Huille, Hannie Shih, and David Kang

• Debunking the Myths of Subcutaneous Delivery Slide Compilation- Moderators: David Kang and Beate Bittner

• Translatability of Preclinical Data to Human BA- Marta Venczel

• Advancing in Vitro Tools to Predict Bioavailability of Biotherapeutics- Kate Harris 

• Myth 4: Subcutaneous Delivery Requires Extensive Clinical Trials When Bridging Device or From IV- Beate Bittner, Gerard Bruin

Workshop: Therapeutic Genome Editing: Tools, Delivery Systems, Prospects and Challenges-1:00 PM - 5:00 PM

• In-Vitro High-Throughput Screening for Delivering Genome Editing Reagents- Dr. Alan Sabirsh

Biologics Summit Part II: Afternoon Session- -1:00 PM - 5:00 PM

• High-Volume Subcutaneous Injection Devices: Pushing the Injection Volume Boundaries-David Kang

• Breakthroughs in Drug Delivery and Medical Devices Part II - Kevin Warner, PhD, Bo Michnia,k PhD, Thanasis Touris, PhD, Diane Burges,s PhD, Catherine Sheehan, PhD

Tuesday, July 9th

Tech Forum: Customized Release Systems for Pulsatile Delivery - A Patient-centric Approach for Chronotherapy- 8:00 AM - 9:00 AM

• Customized Release Systems for Pulsatile Delivery - A Patient-centric Approach for Chronotherapy- Srini Shanmugam, Ph.D.

Tech Forum: Everything Old is New Again: Lactide/Glycolide Polymers Continue to Deliver- 8:00 AM - 9:00 AMTech Forum: Determination of Critical Quality Attributes for ADC, NanoDDS and Gene Delivery tools from Research to Production- 8:00 AM - 9:00 AM

• Everything Old is New Again: Lactide/Glycolide Polymers Continue to Deliver- Jan Hendrik Schattka, EVONIK

Tech Forum: Determination of Critical Quality Attributes for ADC, NanoDDS, and Gene Delivery tools from Research to Production- 8:00 AM - 9:00 AM

• Determination of Critical Quality Attributes (CQAs) for ADC, NanoDDS, and Gene Delivery Tools From Research to Production- Dr. Abhigyan Sengupta and Dr. David Golonka

Tech Forum: Innovative Cationic Lipids for RNA Delivery: Unlocking New Extra-Hepatic Horizons with Tailored 4-Lipid and 5-lipid LNP Formulations- 8:00 AM - 9:00 AM

• LipidBrick®: An Innovative Lipid Library for Efficient and Tunable mRNA-LNPs- Quentin Huaulmé, PhD, and  Claire Guéguen, PhD - Sartorius

Technical Session I - Alternative Methods to Animal Testing- 9:00 AM - 11:00 AM

• Advancing Drug Delivery Science: Integrating State-of-the-Art Organ-Chips for Human-Relevant In Vitro Models to Reduce Animal Studies- Christine Lansche, PhD

• The Anticancer Activity of Miriplatin-loaded Micelles in 3D Multicellular Spheroids and in an Orthotopic Xenograft Lung Cancer Model - Zizhao Xu, Yong Zhu, Xin Guo

• Optimization of In-Vitro Release Setup for In-Situ Forming Depot Technology- Charlotte Peloso 

Technical Session I - Bioengineering I- 9:00 AM - 11:00 AM

• Enabling Intramuscular Injections for Nerve Regeneration In Vivo- Jessica Larsen

• Selective Intracellular Delivery of Antibodies in Cancer Cells with Nanocarrier Responding to Endo/lysosome Hyperacidification- Pengwen Chen

• Self-delivered Transformable Nanosystem for Photodynamic- Immunotherapy of Tumor- Ruyi Lin

• Smart Wound Dressing for Infected Wound Healing and Monitoring Applications- Dr. Zong-Hong Lin

Technical Session I - Long-Acting Drug Delivery Formulations I- 9:00 AM - 11:00 AM

• Injectable Thermosensitive Hydrogel for Cardiac Delivery of Therapeutics- Dr. Cristina Casadidio

• Human Mature Omental Adipocytes Used as a Reservoir for Paclitaxel Delivery to Ovarian Tumor Organoids- Pacome K. Andele

• ROS-Activated Nanocarriers: A Novel Approach to Targeted Cancer Chemotherapy- NURAN CAZ

• 5D3(CC-MLN8237) As a Novel Antibody-theranostic Conjugate for PSMA(+) Prostate Cancer Therapy- Sudath Hapuarachchige, PhD

Technical Session I - Manufacturing Science and Technology- 9:00 AM - 11:00 AM

• Enabling the Next-Generation on-viral Gene Therapy through Lipid-PEG Alternatives Based on Bioinspired Polymers- Aroa Duro Castaño, Curapath, Spain

• Human Leukocyte Antigen-free Biomimetic Proteolipid Vesicles as a Donor-Independent Delivery Platform for Overcoming Alloreactivity- Pasqualina Scala

• Risperidone-loaded PLGA Sustained Release Implants- from Benchtop to Commercial Scale- Patrick Duffy, PhD

Technical Session I - Nanomedicine and Nanoscale Delivery - 9:00 AM - 11:00 AM

• Polymalic Acid-Based Nanoconjugate Passing Blood-Brain Barrier and Targeting Extracellular Matrix Laminin-411 Modulates Brain Immune System to Inhibit Glioblastoma Growth- Alexander V. Ljubimov, PhD

• Combining Two Strategies to Modulate the Tumor Microenvironment and Optimize Efficacy of Nano-Immunotherapy- Fotios Mpekris

• Polymer Theranostics with Multiple Stimuli-Based Activations- Tomáš Etrych, DSc

• Urease-powered Nanobots For Radionuclide Bladder Cancer Therapy- Meritxell Serra-Casablancas

• DRUG-FREE MACROMOLECULAR THERAPEUTICS  MULTI-ANTIGEN T CELL HYBRIDIZERS- JINDŘICH KOPEČEK

• Drug-initiated Synthesis of Polymer-drug Conjugates- Julien Nicolas

Tech Forum: Stability & Palatability of Flavor Excipients--A Winning Combination for Veterinary Drug Formulation - 2:30 PM - 3:30 PM

• Stability & Palatability of Flavor Excipients: A Winning Combination forVeterinary Drug Formulation- Darcy L. Forber,

Tech Forum: De-Risking Oral Controlled Release Dosage Forms, the Corelease Way- 2:30 PM - 3:30 PM

• De-Risking Oral Controlled Release Dosage Forms, the Corelease™ Way- Beth Tran, Ali Rajabi-Siahboomi, Jason Teckoe, Paul Smith

Tech Forum: Excipients and processes: Ensuring successful development and scale-up of solid particles for extended release- 2:30 PM - 3:30 PM

• Excipients and processes: Ensuring Successful Development and Scale-up of Solid Particles for Extended Release- Chad Johnson

Tech Forum: Molecular modeling and machine learning for small molecule and biologic drug formulation- 2:30 PM - 3:30 PM

• Molecular Modeling and Machine Learning for Small Molecule and Biologic Drug Formulation- Irene Bechis, PhD & Dan Cannon, PhD

Technical Session II - Gene Delivery and Gene Editing I- 3:30 PM-  5:30 PM

• Lipid Nanoparticle Formulation Characterization: Bridging the Gap from R&D to GMP- SERGIO ESTEBAN PÉREZ

• Genetic Engineering of Megakaryocytes From Blood Progenitor Cells Using mRNA Lipid Nanoparticles- Jerry Leung

• Extracellular Vesicles Subpopulations Yield Different DNA Encapsulation Efficiencies- Oscar Boyadjian

• Transitioning Hybrid Lipid Polymer Nanoparticles From Lab to Bulk Scale Production with Microfluidic- Ersilia Villano

• A Reducible Carbamate Ionizable Lipid Library Tailored Towards Intramuscular and Systemic Therapeutic Applications- Dr. Sabah Kasmi

Technical Session II - JCR 40th Anniversary: 40 years of Quality Delivery: The Legacy and Future- 3:30 PM-  5:30 PM

• From Antisense Oligonucleotide Degradation to Ocular mRNA Delivery: How the Journal of Controlled Release Shaped My Academic Journey- Katrien Remaut

Technical Session II - Nanomedicine and Nanoscale Delivery II- 3:30 PM-  5:30 PM

• Nanomedicine and Nanoscale Delivery II-Alex Bunker

• Streamlining Granular Hydrogel Fabrication for Drug Delivery- Angeliki Andrianopoulou

• Tail-Flipping’ Nanoliposomes to Target Metastasis-Associated Macrophages in Lung Metastasis-  Kunal P. Pednekar

• Sweetosome: An Easy and Scalable Approach to Produce Sugar-Decorated Liposomes by Microfluidics- Mattia Tiboni, PhD

• Chemotherapeutic Nanomedicines For Simultaneous Brain and GBM Targeted Treatments- Dr. Jason Duskey

Technical Session II - Skin and Mucosal Delivery I- 3:30 PM-  5:30 PM

• Critical Quality Attributes Enhance Understanding of Skin Sensory Perceptions- Dr Yousuf Mohammed

• 3D-printed Lattice Micro-Array Patches (L-MAPs) for Tunable and Versatile Intradermal Delivery- Netra Unni Rajesh

• Lipoic Acid-Mediated Oral Drug Delivery System for the Treatment of Diabetes and Inflammatory Disease- Prof. Yuan Huang

• Dry and Temperature Stable mRNA Vaccine Presentation- Carolin Thiele-Suess, PhD

• A Gas-promoted in Situ Bioadhesive Foam as A  Platform for Antibody Fragment (FAb) Delivery Across the Colon to Treat Inflammatory Bowel Disease- Wunan Zhang

• Dissolving Microarray Patches for Malaria Chemoprophylaxis: Mapping Solid Drug Nanoparticle Incorporation and Long-acting Release in Vivo- Dr Sam Morris

Technical Session II - 2024 CRS/ESMI Joint Session- 3:30 PM-  5:30 PM

• Imaging Heterogeneous Tumor Accumulation and Intratumoral Distribution of Nanoparticles- Xiuling Lu, PhD

• Unveiling the Biological Identity of Lipid Nanoparticles- Kai Liu, PhD

• Engineering Radiocatalytic Liposomes with Hydrophobic Gold Nanoclusters- Mans Broekgaarden

• Model System Characterizing Subcutaneous Long-Acting Injectable Depots- Robert Gresham, P h D

Innovation Showcase- 6:00 PM - 7:30 PM

• Puppies Appreciate GastroPlus® How Model-Informed Drug Development Can Reduce & Focus Clinical Trials Through Simulation- Daniel J. O’Connor, Xavier Pepin, PhD

• Revolutionising Drug-Delivery for Women- Dr Janet Halliday

• Close to the Patient - Addressing Formulation Challenges in Development of Novel Therapies- Lukasz Koroniak

• Digital Formulation of Ocular Implants: In Silico Release Predictions and Microstructure Synthesis of Drug Particle Networks- Joshua Lomeo

• UNLEASHING THE POTENTIAL OF HARD-TO-DELIVER DRUGS- Ruth Schmid

• DynaPro ZetaStar- Dr. David Golonka

Wednesday, July 10th

Tech Forum: Close to the Heart - Biomaterial Developed to Serve Vascular Applications- 8:00 AM - 9:00 AM

• Close to the Heart - Biomaterial Developed to Serve Vascular Applications- Dr. George Mihov, Ph.D

Technical Session III - Delivery Technologies for Diversified Products I-9:00 AM - 11:00 AM

• Sphero Encapsulation- Martina Vakarelova

• Microplastic-Free Microcapsules Using Interfacial Self-Assembly of Bis-Urea Molecules- Siddhant Bhutkar, Pierre-Eric Millard, Jon A. Preece, Zhibing Zhang

• AI-assisted Autonomous Manufacturing of (on-demand, Tailored, Tunable) Drug-Loaded Nanoparticles by Multi-step Continuous-flow Platform- Prof. Dong-Pyo Kim

• Impact of Lipid Composition on Maintaining Bioactivity of mRNA-LNPs in Thermostable mRNA-Vaccines - Behnaz Eshaghi, PhD

• Green Approach for the Activation of Polyphenolic Compounds: In Vivo Evaluation of Novel Cosmetic Formulations- Maria Rosa Gigliobianco, PhD

• Iron-Carbohydrate Complexes Against Anaemia: Elucidating Nano-structure and Nano-Bio Interactions- Leonard Krupnik

Technical Session III - Long-Acting Drug Delivery Formulations II-9:00 AM - 11:00 AM

• Commercial Long-Acting Injectables, State and Perspectives- Adolfo López-Noriega

• P-104, A NOVEL MICROPARTICLE FORMULATION ACHIEVING EXTENDED-RELEASE OF FLUTICASONE PROPIONATE - Dr. Amanda Malone, PhD

• Research Platform Tool: Miniaturized Screening and Tailoring of Preclinical XR-Formulations for NCEs- Marco Block 

Technical Session III - The Upside and Downside of PEGylation and the Emerging Alternatives-9:00 AM - 11:00 AM

• Anti-PEG Antibodies - Biology, Assays, and Significance- Steve Roffler
• Workshop on “The Upside and Downside of PEGylation and the Emerging Alternatives-Dr. Peter van Hoogevest
• Peptide Alternative to PEG in Lipid Nanoparticles: Preliminary Data- Kumar Rajappan, PhD

Technical Session III - Bioengineering II-9:00 AM - 11:00 AM

• Robotics and AI for Synthetic Cells Production- Shanny Ackerman

• Targeted Nanomedical Approaches Against Multiple Myeloma- Zahraa Al-Ahmady

Technical Session III - Nanomedicine and Nanoscale Delivery III- 9:00 AM - 11:00 AM

• Artificial Intelligence for Effective Treatment Selection Using Biodegradable Poly(N-(2-hydroxypropyl) methacrylamide) for Blood Brain Barrier Delivery and Immune Therapy of Brain Primary Central Nervous System Lymphoma- Vladimir Ljubimov, MD, MS

• Combining Retinoic Acid and Calcitriol Delivery for the Recovery of Mature Oligodendrocytes in a Cuprizone Model- Prof. Anne des Rieux

• A Mitochondria-Targeted Polypeptide-Based Nanoconjugate for Breast Cancer Treatment- Camilla Pegoraro

• Modification and Functional Design of Lipid-based Nanocarriers for Efficient Cancer Treatment- Shiqi Huang

• Urease-Powered Nanomotor for Bladder Cancer Immunotherapy- Seok Cheon

Technical Session IV - Delivery to the Nervous System- 2:30 PM - 4:30 PM

• Donepezil Nanoemulsion Induces a Torpor-like State in Non-Hibernating Tadpoles- Dr. Maria Plaza Oliver
• Delivery to the Nervous System- Hannah Jackson

Technical Session IV - Immuno Delivery I-2:30 PM - 4:30 PM

• Tumor-targeted Nanocytokine Boosts Anticancer Immunity through pH-Triggered Inflammation- Horacio Cabral

• A  Modular Nanoparticle Vaccine Platform for Simultaneous Antigen and Adjuvant Delivery to Antigen-Presenting Cells- Anne de Dreu

• Promoting Organ Transplant Survival with Trained Immunity-Inhibiting Nanobiologics- Rianne Maas

• Development of Lipid Nanoparticle for In Vivo Silencing of Negative Immune Checkpoints in Glioblastoma Cancer Stem Cells-  Alaa Zam

Technical Session IV - Nanomedicine and Nanoscale Delivery IV- 2:30 PM - 4:30 PM

• Pirfenidone-loaded Polymeric Micelles as an Effective Mechanotherapeutic to Potentiate Immunotherapy in Mouse Tumor Models- Constantina Neophytou
• Nanomedicine-enabled Methylprednisolone Prodrug Promotes Neuroprotection and Functional Recovery and Mitigates Adverse Effects After Acute Spinal Cord Injury in Rats- Weiping Qin, MD, Ph.D

• Bottom-up Templating of Drug Nanoparticles in Core-shell Hydrogel Particles for Versatile Oral Drug Delivery- Lucas Attia

• Lipid Nanoparticles for Pulmonary Delivery of mRNA- Sams M. A. Sadat

Technical Session IV - Bioengineering III-2:30 PM - 4:30 PM

• Orally Cascade Targeting Delivery Systems Alleviate Colitis by Protecting Mitochondria and Regulating Gut Microbiotics- Liyun Xing

Thursday, July 11th

Tech Forum: Nanomedicines: From Where Are We Coming and Where Are We Going?-  8:00 AM - 9:00 AM

• Accelerating LNP-mediated Nucleic Acid Medicine via a Powerful Ionizable Lipid Library Toolbox- Dr. Eleni Samaridou

Technical Session V - Artificial Intelligence and Predictive Models in Pharmaceutical Technologies-9:00 AM- 11:00 AM

• Artificial Intelligence and Predictive Models in Pharmaceutical Technologies- YAGMUR PİRİNCCİ TOK

• Machine Learning to Predict Extracellular Vesicle Properties for Drug Delivery Applications- Robert D. Kirian

• Computational Simulation for Structural Stability and Formation of DOPC and DPPC Lipid Vesicle Using Coarse- Grained Simulation with Martini Force Field- Prof. Pardeep Gupta

• A novel In-Vivo & In-Silico Approach for Predicting Bioavailability of Subcutaneously Administered Antibody Drugs- Thomas Birngruber, PhD

Technical Session V - Delivery Technologies for Diversified Products II-9:00 AM - 11:00 AM

• Water-Insoluble α-Glucan Polysaccharide Nanoparticles for Controlled Release of Compounds- Kervin O. Evans, Christopher D. Skory, David L. Compton, Michael Appell

• Lipid Submicron Particles Designed to Deliver Peptide to Epidermis- Dra. Renata Raffin

• TiO2-free coatings: Comparing the Degree of Whiteness, Achieved with Titanium Dioxide Free Immediate Release Coatings-Nils Rottmann

• Multi-method Approach to Study the Impact of Major Stressors on Hair Health: Development of Targeted Hair Cosmetic Products- Camilla Elena Di Bella, PhD

• Ultra-long-acting Injectable, Biodegradable, and Removable In-situ Forming Implant with Cabotegravir for HIV Prevention- Thy Le

• 3D Printing vs Traditional Pharmaceuticals- Liam Krueger

Technical Session V - Nanomedicine and Nanoscale Delivery V-9:00 AM - 11:00 AM

• Nanocarriers-Mediated Modulation of Mechanosensitive Pro-Fibrotic Pathway in Myocardium- Enrica Chiesa 

• Metal-Organic Framework for Oral Antibody Delivery in Inflammatory Bowel Disease- Cheng Chen

• Lipid Vesicles Offer a Selective Splenic Targeting Strategy for Peripheral Immunomodulation Following Ischemic Stroke- Dr. Satinderdeep Kaur

• Resolving Sepsis-induced Immunoparalysis via Trained Immunity by Targeting Interleukin-4 to Myeloid Cells- Jeroen Deckers

Technical Session V - Women's Health for Everyone's Health- 9:00 AM - 11:00 AM

• An Experimental Suite for RNA-based EMT Targeting in Breast Cancer- Gabriele Loiudice, PharmD

• Extended-Release Tri-layer Multipurpose Technology (MPT) Films for Vaginal Delivery of Anti-HIV and Contraceptive Drug Combination- Sravan Kumar Patel

• Women’s Health for Everyone’s Health- Kimberly Bockley 

Technical Session VI - Nanomedicine and Nanoscale Delivery VI- 3:30 PM - 5:30 PM

• Nanocarrier Design for Enhanced Batimastat Delivery in Glioblastoma- Miguel Diogo de Freitas Horta

• Identification of a Collagen-Binding Peptide for Nano Theranostics Modification Applied on Enhanced Imaging and Regeneration of Osteoarthritic Articular Cartilage- Chin-Yu Lin

• Biodegradable Polyphosphoester Micelles Act as Background-free 31P MRI Agents and Drug Nanocarriers- Olga Koshkina

• Smart Polymersomes: pH-responsive Nanocarriers for Improved Intestinal Delivery of Immunosuppressants- Matteo Tollemeto

• Combination Therapy Using Semaglutide-loaded Lipid Nanocapsules and a Peptidomimetic Against Integrin ⍺5- Inês Domingues

• Potent B and T cell Responses Provoked by Enzyme-Degradable Nanovesicles- Bi Wang

Technical Session VI - Oral Delivery- 3:30 PM - 5:30 PM

• Continuous Oral Drug Delivery via OraFuse Device- Jennifer Harmon, MBA
• Repurposing an Anticancer Agent for Liver Fibrosis Therapy- Nashmia Zia
• Labrafac MC60 and Capryol® Vivo Models of the Rat Intestine- Fiona McCartney,

Technical Session VI - Ocular Delivery- 3:30 PM - 5:30 PM

• Optimizing Injectable in situ Forming Implants for Sustained Release of Ophthalmic Therapeutics- Valerie Eta D. Sc (Tech)

• Bioinspired Contact Lenses that Deliver Antioxidant Agents- CARMEN ALVAREZ-LORENZO

• Absolute Quantitation of Barcoded Liposomes in Ocular Tissues- Arto Merivaara, PharmD

• Novel Acetazolamide-loaded Nnostructured Lipid Carriers for Ocular Applications- María L. Formica

• Antifibrotic Drug Delivery Theramem to Stimulate Scarless Corneal Wound Healing- Ghanashyam Acharya, PhD

• Resistance of Topical Ophthalmic Drug Products in the Nvel in-Vitro Ophthalmic Device- Prof. Dra. Taís Gratieri

Technical Session VI - Immuno Delivery II- 3:30 PM - 5:30 PM

• Split Bullets Loaded Nanoparticles Dually Targeting Mitochondria and Endoplasmic Reticulum for Amplified Chemo-Immunotherapy- Chendong Liu

• Engineering Nanoparticle Systems to Target Lymphatics and their Underlying Cellular Mechanisms- Dr. Katharina Maisel

• Lyophilized Lymph Nodes for Improved Delivery of CAR T Cells- Jiaqi Shi

• Principles for Enhancing the Stability of Cytokines in Polymeric Nanoparticle Delivery Platforms- Nicole B. Day

• Chronic Inflammation in Obesity

Technical Session VI - Gene Delivery and Gene Editing II- 3:30 PM - 5:30 PM

• Engineered Extracellular Vesicles (EVs) for Targeted Ligand Display and Therapeutic Protein Delivery- Elisa Lázaro Ibáñez
• Gene Delivery and Gene Editing II- Olivia Merkel

• Targeted Cellular Delivery of CRISPR-Cas 9 Ribonucleoproteins using Dendrimer Nanoparticles- Wathsala Liyanage

• Tardigrade-based mRNA Therapy for Radioprotection- Ameya Kirtane, PhD

Friday, July 12th

Technical Session VII - Bioengineering IV- 8:00 AM - 10:00 AM

• Catalyzing Therapeutic Breakthroughs:  Engineering Targeted Extracellular Vesicles for  Liver Fibrosis Treatment- Revadee Liam-Or

• Enhancing Nano-Immunotherapy Efficacy in Mouse Sarcoma Models Through Tumor Microenvironment Reprogramming- Antonia Charalambous, PhD

• Swarms of Enzyme-Powered Nanomotors Enhance the Diffusion of Macromolecules in Viscous Media- Noelia Ruiz González

• Towards Bioengineering: Optimization of a New Probucol-Bile Acid Delivery System for Inflammatory/Stress Conditions - Method Optimization and In-Vitro Study- Susbin Raj Wagle

Technical Session VII - Nanomedicine and Nanoscale Delivery VIII-8:00 AM - 10:00 AM

• Enhancing Tumor-Targeting Bacteria Efficacy via Smart Polymer Shield Encapsulation- Quentin Boussau, PhD

• Viral/nonviral Nanoparticles as Promising Vectors for Gene Transfection to the Eye- Sílvia L. Fialho, Ph.D.

• RAVIOLI: A Hyaluronic Acid-Based Platform for the Treatment of Post-Traumatic Osteoarthritis- Dr. Antonietta Greco, PhD

• Yttrium-90-Doped Biocompatible Metal-Organic Frameworks for Low-dose Rate Internal Radiation Therapy- Dr. Mikhail Durymanov, PhD

• Novel Nanohydrogel Based on a Conjugate Between Sericin and Hyaluronic Acidic Acid- Piera Di Martino

• Myeloid Cell-nanospy System Rebalances the Immunosuppressive State of HCC Pre-metastatic Niche to Inhibit Metastasis- Dr. Weiwei Mu

Technical Session VII - Skin and Mucosal Delivery III-8:00 AM - 10:00 AM

• ADVANCES IN CONTROLLED TRANSDERMAL DELIVERY OF ANTITUBERCULAR DRUGS-  NESTERKINA MARIIA

• ­Clinical Trial to Investigate the Tolerability of a Rapid 10 mL Subcutaneous Injection of a Biologic Drug with Recombinant Human Hyaluronidase (rHuPH20) Using a High-Volume Auto-Injector (HVAI) in Healthy Subjects- David Kang

• Protein-Loaded Biomaterial-Based Composite Scaffolds for Potential Healing of Chronic Wounds- Prof Joshua Boateng, Dr Meena Afzali

• A Multi-stage Pulmonary Drug Delivery System Based on Pollen Grains- LORENA VALVERDE-FRAGA